The initial drug treatment of older patients with Parkinson's disease - Consider an agonist, but don't demonise dopa

Age and Ageing

Volumn 32, Issue 3, 2003, Pages 244-245

  MacMahon, Douglas G ^a  

^a Camborne/Redruth Community Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMPHETAMINE; ANTIPARKINSON AGENT; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; ERGOLINE DERIVATIVE; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEW DRUG; PERGOLIDE MESILATE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE;

AGED; COMORBIDITY; CROSS REACTION; DEMENTIA; DISEASE COURSE; DOPAMINERGIC ACTIVITY; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EDEMA; EDITORIAL; GERIATRIC CARE; HALLUCINATION; HUMAN; INSOMNIA; LIFE EXPECTANCY; LONG TERM CARE; LOW DRUG DOSE; MOTOR DYSFUNCTION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SOMNOLENCE; SYMPTOM;

ANTIPARKINSON AGENTS; BENZOTHIAZOLES; CATECHOL O-METHYLTRANSFERASE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOLES; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE; PERGOLIDE; THIAZOLES;

EID: 0038446590     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/32.3.244     Document Type: Editorial

References (12)

1. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000; 342: 1484-91.
2. Parkinson's Study Group. Pramipexole vs levodopa as initial treatment for Parkinson's disease: A randomized controlled trial. JAMA 2000; 284: 1931-8.
3. Oertel WH. Pergolide vs L-dopa (PELMOPET). Mov Disord 2000; 15 (suppl 3): 4.
4. Whone A, Brooks D. REALPET. Abstract, American Academy of Neurology, Denver, April 2002.
5. Marek K, Seibyl J, Shoulson I, et al. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002; 287: 1653-61.
6. Fahn S. The ELLDOPA Study. Conference presentation, Movement Disorders, Miami, November 2002.
7. Shulman LM, Minagar A, Rabinstein A, Weiner WJ. The use of dopamine agonists in very elderly patients with Parkinson's disease. Mov Disord 2000; 15: 664-8.
8. Primary Care Task Force. Parkinson's aware in primary care. A guide for primary care teams developed by the primary care task force for PDS (UK), Second edition. 1999; Parkinson's Disease Society, London.
9. Bhatia K, Brooks DJ, Burn DJ, et al. Updated guidelines for the management of Parkinson's disease. Hosp Med 2001; 62: 456-70.
10. Olanow CW, Watts RL, Koller WC. An Algorithm (Decision Tree) for the Management of Parkinson's Disease. Neurology 2001; 56 (suppl 5): S1-88.
11. Practical approach to quality of life in Parkinson's disease. MacMahon DG, Thomas S. J Neurol 1998; 245 (suppl 1): S19-22.
12. MacMahon D. Treatment of Parkinson's disease. Prescriber 2002: 5 Jan: 21-32.